CASTLE BIOSCIENCES, INC. (CSTL) Free cash flow 2018–2025
CASTLE BIOSCIENCES, INC. (CSTL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$28.3MFY2025 · since FY2018: -$12.6M → $28.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $28.3M | -22.5% |
| FY2024 | $36.5M | +289.8% |
| FY2023 | -$19.2M | +59.3% |
| FY2022 | -$47.3M | -110.5% |
| FY2021 | -$22.5M | -539.3% |
| FY2020 | $5.1M | -15.9% |
| FY2019 | $6.1M | +148.3% |
| FY2018 | -$12.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSTL financial trends
CSTL RevenueCSTL Net incomeCSTL Net marginCSTL Gross profitCSTL Gross marginCSTL Operating incomeCSTL Operating marginCSTL Operating cash flowCSTL Capital expendituresCSTL Return on equityCSTL Stock buybacksCSTL Dividends paidCSTL Total assetsCSTL Total liabilitiesCSTL Shareholders’ equityCSTL overview →